CAS: 202808-11-5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | MRZ 2-514 REF: TM-T12110CAS: 202808-11-5 | 98.13% | 96,00 €~1.483,00 € | Mar 15 Abr 25 |
 | MRZ 2-514 REF: IN-DA01EOBCCAS: 202808-11-5 | 99% | A consultar | Mar 15 Abr 25 |
 | MRZ 2-514 REF: 54-BUP12574CAS: 202808-11-5 | 98.12% | 960,00 €~4.939,00 € | Lun 14 Abr 25 |
 | MRZ 2/514 REF: 3D-CIA80811CAS: 202808-11-5 | Min. 95% | 497,00 €~4.210,00 € | Mar 27 May 25 |
MRZ 2-514
CAS:202808-11-5
MRZ 2-514 (8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one) is a strychnine-insensitive modulatory site of the NMDA receptor (glycineB)antagonist with Ki
Fórmula:
C11H6BrN3O3
Pureza:
98.13%
Forma y color:
Solid
Peso molecular:
308.09
Ref: TM-T12110
| 1mg | 96,00 € | ||
| 5mg | 202,00 € | ||
| 10mg | 329,00 € | ||
| 25mg | 655,00 € | ||
| 50mg | 1.103,00 € | ||
| 100mg | 1.483,00 € | ||
| 1mL*10mM (DMSO) | 224,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025
Ref: IN-DA01EOBC
| 1mg | 229,00 € | ||
| 5mg | 643,00 € | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025
Ref: 54-BUP12574
| 1g | 4.939,00 € | ||
| 25mg | 960,00 € | ||
| 50mg | 1.492,00 € | ||
| 100mg | 2.006,00 € | ||
| 500mg | 3.678,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025
MRZ 2/514
CAS:202808-11-5
Please enquire for more information about MRZ 2/514 including the price, delivery time and more …
Fórmula:
C11H6BrN3O3
Pureza:
Min. 95%
Peso molecular:
308.09 g/mol
Ref: 3D-CIA80811
| 1mg | 497,00 € | ||
| 5mg | 1.441,00 € | ||
| 10mg | 2.246,00 € | ||
| 25mg | 4.210,00 € |
Entrega estimada en Estados Unidos, el Martes 27 de Mayo de 2025
